Client Profile
Zogenix
5858 Horton, Emeryville CA
Landlord:
Wareham Development
Square Feet:
4,170
Zogenix is a recently funded Series A company whose
management was spinning out of
Aradigm Corporation. Con dentiality
was crucial and Aegis scoured the
market to acquire a short term deal
with expansion rights built into the
deal. Aegis negotiated quickly for a
space that contained most of the
needed infrastructure and the set up
of a small lab. Zogenix was moving
from an industrial area and Aegis
helped them move to a commute
central location in Emeryville that was
close to many amenities.
Zogenix, Inc. is a private, specialty pharmaceutical
company focused on the development and
commercialization of medicines to treat CNS
disorders and pain. Zogenix' initial focus is the
global development and commercialization of
sumatriptan Intraject® -- a needle free, single
use, disposable, subcutaneous delivery system
that will compete in the $2.5 billion triptan
segment of the migraine market.
